JUHI NAYEEM: Open Payments
NPI 1689767568 · LAUREL, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$271 in 11 payments from 5 companies in 2025. Trend: 2023 $1,440 · 2024 $1,387 · 2025 $271
Food & beverage: $271
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 3 | $104 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $85 |
| ABBVIE INC. | 2 | $36 |
| TMS NeuroHealth Centers Inc. | 1 | $26 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
Products named: INVEGA SUSTENNA, CAPLYTA, VRAYLAR, TMS NeuroHealth Centers Inc., Qelbree.
Industry payments across MD — which companies pay providers there.
